ונקו-טבע 500 מג ישראל - עברית - Ministry of Health

ונקו-טבע 500 מג

teva pharmaceutical industries ltd, israel - vancomycin as hydrochloride - אבקה מיובשת בהקפאה להזרקה - vancomycin as hydrochloride 500 mg/vial - vancomycin - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal

פלולן אפופרוסטנול 500 מקג לעירוי ישראל - עברית - Ministry of Health

פלולן אפופרוסטנול 500 מקג לעירוי

glaxo smith kline (israel) ltd - epoprostenol as sodium - אבקה להכנת תמיסה לאינפוזיה - epoprostenol as sodium 0.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

קסינתה 500 יחבל ישראל - עברית - Ministry of Health

קסינתה 500 יחבל

pfizer pharmaceuticals israel ltd - moroctocog alfa - אבקה מיובשת בהקפאה להזרקה - moroctocog alfa 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

בנפיקס 500 יח' בינל ישראל - עברית - Ministry of Health

בנפיקס 500 יח' בינל

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - אבקה מיובשת בהקפאה להזרקה - coagulation factor ix recombinant-rfix 500 iu/vial - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup).benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.

מתילפרדניזולון ויאטריס 500 מג ישראל - עברית - Ministry of Health

מתילפרדניזולון ויאטריס 500 מג

genmedix , israel - methylprednisolone as hemisuccinate - אבקה מיובשת בהקפאה להזרקה - methylprednisolone as hemisuccinate 500 mg/vial - methylprednisolone - methylprednisolone - when corticosteroid therapy is required, but the general oral administration route connot be used (vomiting, gastric aspiration, sensorial disturbances) and the parenteral route is necessary.

סולו קורטף 500 ישראל - עברית - Ministry of Health

סולו קורטף 500

pfizer pfe pharmaceuticals israel ltd - hydrocortisone as sodium succinate - אבקה להמסה להזרקה\אינפוזיה - hydrocortisone as sodium succinate 500 mg/vial - hydrocortisone - hydrocortisone - glucocorticosteroid anti-inflammatory and anti-allergic

פניברין 500 מג ישראל - עברית - Ministry of Health

פניברין 500 מג

abic marketing ltd, israel - ampicillin as sodium - אבקה להמסה להזרקה\אינפוזיה - ampicillin as sodium 500 mg/vial - ampicillin - ampicillin - infections caused by susceptible organisms.

פיפרצילין טזובקטם פאנפרמה 4 גרם 500 מג ישראל - עברית - Ministry of Health

פיפרצילין טזובקטם פאנפרמה 4 גרם 500 מג

pharmalogic ltd - piperacillin as sodium; tazobactam as sodium - אבקה להכנת תמיסה לאינפוזיה - piperacillin as sodium 4 g; tazobactam as sodium 500 mg - tazobactam - tazobactam - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. pipoeracillin/tazobactam in combination with an aminoglycoside is indicated for suspected bacterial infections in neutropenic adults or children above 2 years . appencicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

אוגמנטין  500 מג  זריקות ישראל - עברית - Ministry of Health

אוגמנטין 500 מג זריקות

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 500 mg; clavulanic acid as potassium clavulanate 100 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactam antibiotics.

מרונם  500 מג ישראל - עברית - Ministry of Health

מרונם 500 מג

pfizer pfe pharmaceuticals israel ltd - meropenem as trihydrate - אבקה להכנת תמיסה לזריקה - meropenem as trihydrate 500 mg/vial - meropenem - meropenem - meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.